Management of psychologic factors in chronic urticaria. When and how?;Quand faut-il envisager leur prise en charge? Selon quelles modalités?

Annales de Dermatologie et de Venereologie

Volumn 130, Issue SPEC. ISS. 1, 2003, Pages

  Buffet, M ^a  

^a Hôpital Tarnier Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BENZODIAZEPINE; BUSPIRONE; CHLORPHENIRAMINE; CHLORPROMAZINE; CIMETIDINE; CLOMIPRAMINE; CLOTIAZEPAM; CLOZAPINE; DIPHENHYDRAMINE; DIPHENHYDRAMINE THEOPHYLLINATE; DOXEPIN; FLUDIAZEPAM; FLUOXETINE; HYDROXYZINE; IMIPRAMINE; LORAZEPAM; MAPROTILINE; MEQUITAZINE; MIANSERIN; MIRTAZAPINE; NEFAZODONE; NORSET; NORTRIPTYLINE; OLANZAPINE; PSEUDOEPHEDRINE PLUS TRIPROLIDINE; PSYCHOTROPIC AGENT; SERTRALINE; TRANDOLAPRIL PLUS VERAPAMIL; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG;

ANXIETY DISORDER; APPETITE DISORDER; BEHAVIOR THERAPY; CHRONIC URTICARIA; CLINICAL TRIAL; COCHRANE LIBRARY; CONFERENCE PAPER; CONSTIPATION; DATA BASE; DEPRESSION; DISEASE ASSOCIATION; DRUG ACTIVITY; EMBASE; FATIGUE; GROUP THERAPY; HUMAN; HYPNOSIS; MEDLINE; MENTAL DISEASE; PATIENT CARE; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; SIDE EFFECT; SOMNOLENCE; STRESS; SYMPTOMATOLOGY; URINE RETENTION; ANXIETY; CHRONIC DISEASE; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HISTAMINE RELEASE; MENTAL STRESS; PHYSIOLOGY; PSYCHOSOMATIC DISORDER; REVIEW; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; URTICARIA;

ANXIETY; CHRONIC DISEASE; CONTROLLED CLINICAL TRIALS; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; HISTAMINE RELEASE; HUMANS; HYPNOSIS; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; QUALITY OF LIFE; SINGLE-BLIND METHOD; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; URTICARIA;

EID: 18544409014     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (59)

1. Kozel MMA, Mekkes JR, Bossuyt PMM, Bos JD. Natural course ol physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001;45:387-91.
2. Champion RH, Robert SOB, Carpenter RH, Roger JG. Urticaria and angio-oedema: a review of 544 patients. Br J Dermatol 1969;81:588-97.
3. th Ed. Oxford, England: Blackwell Scientific Publications; 1998:2113-39.
4. th Ed. Oxford, England: Blackwell Scientific Publications; 1998:2785-813.
5. Koblenzer CS. Psychosomatic concepts in dermatology. Arch Dermatol 1983;119:501-12.
6. Guillet G, Garcia C, Guillet MH. Urticaire et psychisme: du constat clinique aux neuropeptides. Rev Fr Allergol 1998;38:401-4.
7. Badoux A, Guinnepain MT, Duchanel D. Les facteurs psychosociaux dans les urticaires chroniques. Rev Fr Allergol 1991;31:105-9.
8. Badoux A, Levy DA. Psychologic symptoms in asthma and chronic urticaria. Ann Allergy 1994;72:229-34.
9. Fava GA, Perini GI, Santonastaso P, Fornasa CV. Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 1980;53:277-82.
10. Sperber J, Shaw J, Bruce S. Psychological components and the role of adjunct interventions in chronic idiopathic urticaria. Psychother Psychosom 1989;51:135-41.
11. Hashiro M, Okomura M. Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria. J Dermatol Sci 1994;8:129-35.
12. Lyketsos GC, Stratigos J, Tawil G, Psaras M, Lyketsos CG. Hostile personality characteristics, dysthymic states and neurotic symptoms in urticaria, psoriasis and alopecia. Psychother Psychosom 1985;44:122-31.
13. Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticaria. Psychosomatic Medicine 1994;56:36-40.
14. Hein UR, Henz BM, Haustein UF, Seikowski K, Aberer W, Lautenschlager S, Klapp BF. Correlation between chronic urticaria and depression/somatization disorder. Hautarzt 1996;47:20-3.
15. Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 1990;123:769-74.
16. Guillet G, Chanal I. Urticaire chronique. Réal Ther Dermatol 1998;74: 16-7.
17. Pistiner M, Pitlik S, Rosenfeld J. Psychogenic urticaria. Lancet 1979;2: 1383.
18. Green GR, Koelsche GA, Kierland RR. Etiology and pathogenesis of chronic urticaria. Ann Allergy 1965;23:30-6.
19. Teshima H, Kubo C, Kihara H et al. Psychosomatic aspects of skin diseases from the standpoint of immunology. Psychother Psychosom 1982;37:165-75.
20. Kimyai-Asadi A, Usman A. The role of psychological stress in skin disease. J Cutan Med Surg 2001;5:140-5.
21. Czubalski K, Rudzki E. Neuropsychic factors in physical urticaria. Dermatologica 1977;154:1-4.
22. Chue PW. Acute angioneurotic edema of the lips and the tongue due to emotional stress. Oral Surg Oral Med Oral Pathol 1976;41:734-8.
23. Stewart JH, Goodman MM. Earthquake urticaria. Cutis 1989;43:340
24. Longley AJ, Fiset L, Getz T, Van Arsdel PP, Weinstein P. Fear can mimic latex allergy in patients with dental phobia. Gen Dent 1994;42:236-40.
25. Shelley WB, Shelley ED. Adrenergic urticaria: a new form of stress-induced hives. Lancet 1985;2:1031-3.
26. Haustein UF. Adrenergic urticaria and adrenergic pruritus. Acta Derm Venereol 1990;70:82-4.
27. Harvey NS, Mikhail WI. Seasonal hypomania in a patient with cold urticaria. Br J Psychiatry 1986;149:238-41.
28. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136: 197-201.
29. Caine N, Harrison SCW, Sharples LD et al. Prospective study of quality of life before and after coronary artery bypass grafting. Br Med J 1991;302:511-6.
30. Nottingham Health Profile. http://195.101.204.50:443/public/NHP.html
31. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-71.
32. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clinical and Experimental Dermatology 1994;19:210-6.
33. Koo JYM, Pham CT. Psychodermatology: Practical Guidelines on pharmacotherapy. Arch Dermatol 1992;128:381-8.
34. Susskind W. Psychosomatic aspects of skin disease. The practitioner 1972;208:298-306.
35. Augustin M, Zschocke I, Koch A, Schopf E, Czech W. Psychological status and motivation for psychosocial intervention in patients with allergic disorders. Hautarzt 1999;50:422-7.
36. Keegan DL. Chronic urticaria: clinical psychophysiological and therapeutic aspects. Psychosomatics 1976;17:160-3.
37. Sanger MD. Psychosomatic approach to allergic dermatoses. Ann Allergy 1968;26:314-20.
38. Y a-t-il une indication pour les sédatifs en dermatologie ? Ann Dermatol Venereol 1995;122:637-9.
39. Russel BF. Emotional factors in skin disease. Br J Psychiatry 1975;spec. n°9:447-52.
40. Goldsobel AB, Rohr AS, Siegel SC, Spector SL, Katz RM, Rachelefsky GS et al. Efficacity of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1986;78:867-73.
41. Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985;12:669-75.
42. Harto A, Sendagorta E, Ledo A. Doxepin in the treatment of chronic urticaria. Dermatologica 1985;170:90-3.
43. Gupta MA, Gupta AK. Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants? Cutis 1995;56:53-4.
44. Morley WN. Nortriptyline in the treatment of chronic urticaria. Br J Clin Pract 1969 23:305-6.
45. Hashiro M, Yamatodani Y. A combination therapy of psychotropic drugs and antihistaminics or anti-allergics in patients with chronic urticaria. J Dermatol Sci 1996;11:209-13.
46. Gupta MA, Gupta AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol 2001;128:512-8.
47. Stoeber PE, Ligeron C, Meunier L, Meynadier J. Antihistaminiques. «Thérapeutique dermatologique»: éd. Dubertret L, Paris: Flammarion 2001:929-35.
48. Hashiro M. Psychosomatic treatment of a case of chronic urticaria. J Dermatol 1995;22:686-9.
49. Rudzki E, Wlodzimierz B, Krzysztol C. The suggestive effect of placebo on the intensity of chronic urticaria. Acta Allergol 1970;25:70-3.
50. Shenefelt PD. Hypnosis in dermatology. Arch Dermatol 2000;136: 393-9.
51. Black S. Inhibition of immediate-type hypersensitivity response by direct suggestion under hypnosis. BMJ 1963;1:925-9.
52. Laidlaw TM, Richardson DH, Booth RJ, Large RG. Immediate-type hypersensitivity reactions and hypnosis: problems in methodology. J Psychosom Res 1994;38:569-80.
53. Laidlaw TM, Booth RJ, Large RG. Reduction in skin reactions to histamine after a hypnotic procedure. Psychosom Med 1996;58:242-8.
54. Guillet G, Favennec F, Ciavaldini P. Effets de l'hypnose-relaxation sur le test à l'histamine: des perspectives en thérapeutique? Rev Fr Allergol 1999;39:561-3.
55. Levine MI, Geer JH, Kost PF. Hypnotic suggestion and the histamine wheal. J Allergy. 1966;37:246-50.
56. Daniels LK. Treatment of urticaria and severe headache by behavior therapy. Psychosomatica 1973;15:347-51.
57. Shertzer CL, Lookingbill DP. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol 1987;123:913-6.
58. Melin L, Frederiksen T, Noren P et al. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol 1986;115:467-74.
59. Schulte MB, Cormane RH, van Dijk E et al. Group therapy of psoriasis. J Am Acad Dermatol 1985;12:61-6.